Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus

författare

Antonio Cassone

publicerad i: Pathogens and Global Health

utgivningsår: 2017-01-12

huvudämne: pandemi, Vaccinia virus

Refererar artiklar 31

Datum

Titel

Författare

2015-09-18

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

Wouter Koudstaal, Jaap Goudsmit, Ian Wilson, Andrew B Ward
2015-08-24

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

Masaru Kanekiyo, John R. Gallagher, Syed Mohammad Moin, Gary Nabel, Barney S. Graham, Peter D. Kwong, John R. Mascola, Lingshu Wang, Wing-Pui Kong, M Gordon Joyce, Hadi M Yassine, Jeffrey C Boyington, Hanne Andersen, Srinivas Rao, Chih-Jen Wei, Patrick M McTamney, Audray K Harris, Daniel Lingwood
2015-03-01

Advances in the development of influenza virus vaccines.

Peter Palese, Florian Krammer
2014-07-17

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases

Gerd Sutter, Rory D. de Vries, Robert Fux, Asisa Volz, Joost H C M Kreijtz, Arwen F Altenburg, Fei Song, Guus Rimmelzwaan
2014-06-09

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

Nigel J. Temperton, Francesca Ferrara
2014-05-30

Continuing challenges in influenza.

Elena Govorkova
2014-02-28

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 20

Colin A Russell, Ian G. Barr, Anne Kelso, Othmar G Engelhardt, Ruben O Donis, Richard Webby, Takato Odagiri, Nancy Cox, Stacey Schultz-Cherry, Yuelong Shu, Gary Grohmann, Dayan Wang, John W McCauley, Wenqing Zhang
2014-02-11

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

Thomas R Kreil, Helga Savidis-Dacho, P Noel Barrett
2014-02

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Gene S. Tan, Peter Palese, Jeffrey Ravetch, David J DiLillo
2014-01-08

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets

Adolfo García-Sastre, Florian Krammer, Gene S. Tan, Victor H Leyva-Grado, Matthew S Miller, Peter Palese, Randy A. Albrecht, Mark Yondola
2013-12-23

Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.

Yoshihiro Kawaoka
2013-12-16

Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

Yuan Lu
2013-12-04

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge

Peter Palese, Florian Krammer, Irina Margine, Ariana Hirsh
2013-10

Influenza virus hemagglutinin stalk-based antibodies and vaccines

Florian Krammer, Peter Palese
2013-07-31

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses

Florian Krammer, Gene S. Tan, Randy A. Albrecht, Adolfo García-Sastre, Irina Margine, Peter Palese
2013-04-10

Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies

Florian Krammer, Peter Palese, Irina Margine, Natalie Pica
2013-01-01

Delayed-type hypersensitivity models in mice
2012-09-26

Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge
2012-03-07

Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes

Peter Palese, Gene S. Tan, Randy A. Albrecht, Florian Krammer, Irina Margine, Natalie Pica, Dirk Eggink, Jad Maamary
2011-08-12

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

Antonio Lanzavecchia, Federica Sallusto, Siro Bianchi, Nigel J. Temperton, Gloria Agatic, David Jarrossay, John Skehel
2011-04-01

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

John H. Beigel, Jianhua Sui
2010-11-30

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

Zuzana Staneková, Eva Varečková
2010-04-12

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

Nigel J. Temperton, Kanta Subbarao, Federica Sallusto, Antonio Lanzavecchia
2010-04-01

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

Adolfo García-Sastre, Peter Palese, Anice C. Lowen, Mark Yondola, Qinshan Gao, Taia T Wang
2009-03

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Jianhua Sui, Ruben O Donis, Nancy Cox
2009-09-22

The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use.

Ilaria Capua, Giulia Di Lullo, Volker Erfle
2007-01-01

Effector and memory CTL differentiation
2007-01-11

Efficient vagina-to-lower respiratory tract immune trafficking in a murine model of influenza A virus infection

Yoshihiro Kawaoka
2006-12-20

Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection

James E. Crowe, Jr.
2000-10-01

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

Carolyn B Bridges, Nancy Cox
1996-07-01

The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region

Artikel - wd:Q30397410

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer